---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-24-056937"
form_type: "8-K"
ticker: "ACRV"
cik: "0001781174"
company_name: "Acrivon Therapeutics, Inc."
filed_at: "2024-03-04T23:59:59+00:00"
generated_at: "2026-06-05T04:49:46.081001+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# Acrivon appoints Santhosh Palani, Ph.D., CFA, to board of directors effective March 4, 2024

## Summary
- Dr. Palani appointed board member effective March 4, 2024; receives 32,500 share option grant vesting over 3 years.
- He brings experience as former investment partner at PFM Health Sciences and prior roles at NEA, Cowen, Pfizer, Takeda.
- No transactions requiring disclosure under Item 404(a); standard indemnification agreement entered.

## SEC filing metadata
- accession: 0001193125-24-056937
- form_type: 8-K
- ticker: ACRV
- cik: 0001781174
- company_name: Acrivon Therapeutics, Inc.
- filed_at: 2024-03-04T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1781174/000119312524056937/0001193125-24-056937-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1781174/000119312524056937/d791106d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-24-056937
- JSON: https://secwatch.observer/filing/0001193125-24-056937.json
- Plain text: https://secwatch.observer/filing/0001193125-24-056937.txt

## Key facts
- Executive change
  Santhosh Palani, Ph.D., CFA was appointed as director at Acrivon Therapeutics, Inc..
  - Action: appointed
  - Role: director
  source text: On March 1, 2024, the Board of Directors of Acrivon Therapeutics, Inc. (the “Company”) appointed Santhosh Palani, Ph.D., CFA, as a director of the Company, effective March 4, 2024.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1781174/000119312524056937/0001193125-24-056937-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.